Invetx Announces Industry-Leading Antibody Discovery Platform to Develop Portfolio of Novel Therapeutics for Animal Health

Platform Leverages Best-in-Class Technologies from AbCellera, Twist Bioscience and WuXi Biologics BOSTON, Mass. – July 16, 2020 – Invetx, a pioneer in protein-based therapeutics for

Twist Bioscience Partners with Invetx to Deliver Best-in-Class Antibody Therapeutics for Dogs and Cats

SOUTH SAN FRANCISCO and BOSTON, Mass. – July 16, 2020 – Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering

Invetx Announces $15 Million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development

Anterra Capital leads financing to advance Invetx’s pipeline of veterinary biologic drugs leveraging breakthroughs in human biopharma Global biologics CDMO WuXi Biologics makes equity investment